Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

Completed · Phase 2/Phase 3

Conditions studied: HIV Infections, Hepatitis C

In brief

The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.

Key facts

Study ID

NCT00164372

Run by

Centers for Disease Control and Prevention

People needed

1400

Starts

2002-05-01

Expected to finish

2006-12-01

Last updated by the study team

2012-09-27

Who can join

Age: 15 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• age 15-30 years old
• self-reported illicit drug injection within the past 6 months
• live in the geographic region under study and plan to stay for >12 months
• willing to provide a blood sample for serologic testing
• willing to provide basic contact information for follow-up
• able to communicate in English
• had not participated in the pilot study or previously enrolled in the trial
• not concurrently participating in other HIV or HCV intervention trials
• tested HIV and HCV seronegative at baseline

Where it is running

• Health Research Association — Los Angeles, California, United States
• University of Illinois at Chicago — Chicago, Illinois, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• New York Academy of Medicine — New York, New York, United States
• Public Health Seattle and King County — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.